SATRIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Satric, and when can generic versions of Satric launch?
Satric is a drug marketed by Savage Labs and is included in two NDAs.
The generic ingredient in SATRIC is metronidazole. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Satric
A generic version of SATRIC was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for SATRIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Clinical Trials: | 1 |
Patent Applications: | 3,934 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SATRIC at DailyMed |
Recent Clinical Trials for SATRIC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sidney Kimmel Cancer Center at Thomas Jefferson University | Early Phase 1 |
Thomas Jefferson University | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for SATRIC
US Patents and Regulatory Information for SATRIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Savage Labs | SATRIC | metronidazole | TABLET;ORAL | 070029-001 | Mar 19, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Savage Labs | SATRIC | metronidazole | TABLET;ORAL | 070731-001 | Jun 8, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |